Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | ATP4A | P20648 | 3/20 | 0.36 |
| ▸ | ATP4B | P51164 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4731101 | 1.00 | RET (0.36) | RETKDRATP4AATP4BCYP3A4 | |
| SCHEMBL4981356 | 0.83 | ATP4A (0.35) | ATP4AATP4BCYP3A4CYP2C9MEN1 | |
| SCHEMBL5557033 | 0.82 | ATP4A (0.34) | ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL5557163 | 0.81 | ATP4A (0.35) | ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL6487366 | 0.81 | ATP4A (0.35) | ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL5652760 | 0.81 | ATP4A (0.32) | ATP4AATP4BCYP3A4CYP2C9SMN1; SMN2 | |
| SCHEMBL4733704 | 0.80 | L3MBTL1 (0.36) | ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL4731646 | 0.79 | RET (0.36) | RETKDRCYP3A4CYP2C9MEN1 | |
| SCHEMBL1816326 | 0.79 | ATP4A (0.40) | ATP4AATP4BCYP3A4CYP2C9CYP2D6 | |
| SCHEMBL4591400 | 0.79 | ATP4A (0.40) | ATP4AATP4BCYP3A4CYP2C9CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0984969-B1 | FUSED DIHYDROPYRANS | NYCOMED GMBH (DE) | 2008-07-09 | — | — | EP | claimed |
| US-6160119-A | Fused dihydropyrans | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2000-12-12 | — | — | US | claimed |
| EP-0984969-A1 | FUSED DIHYDROPYRANS | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2000-03-15 | — | — | EP | claimed |
| WO-1998054188-A1 | FUSED DIHYDROPYRANS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1998-12-03 | — | — | WO | claimed |
| US-7951398-B2 | Pharmaceutical preparation comprising an active dispersed on a matrix | NYCOMED GMBH (DE) | 2011-05-31 | — | — | US | disclosed |
| US-20090048287-A1 | Compositions useful for treating gastrointestinal motility disorders | EDUSA PHARMACEUTICALS, INC. | 2009-02-19 | — | — | US | disclosed |
| EP-0984969-B1 | FUSED DIHYDROPYRANS | NYCOMED GMBH (DE) | 2008-07-09 | — | — | EP | disclosed |
| US-20070122474-A1 | Pharmaceutical preparation comprising an active dispersed on a matrix | ALTANA PHARMA AG | 2007-05-31 | — | — | US | disclosed |
| US-20060189648-A1 | Compositions useful for increasing lower esophageal sphincter pressure | EDUSA PHARMACEUTICALS, INC. | 2006-08-24 | — | — | US | disclosed |
| US-20050059704-A1 | Compositions useful for treating gastrointestinal motility disorders | DYNOGEN PHARMACEUTICALS, INC. (US) | 2005-03-17 | — | — | US | disclosed |
| EP-1341527-A1 | PHARMACEUTICAL PREPARATION COMPRISING AN ACTIVE DISPERSED ON A MATRIX | ALTANA Pharma AG (DE) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002045693-A1 | PHARMACEUTICAL PREPARATION COMPRISING AN ACTIVE DISPERSED ON A MATRIX | ALTANA PHARMA AG (DE) | 2002-06-13 | — | — | WO | disclosed |
| US-6160119-A | Fused dihydropyrans | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2000-12-12 | — | — | US | disclosed |
| EP-0984969-A1 | FUSED DIHYDROPYRANS | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2000-03-15 | — | — | EP | disclosed |
| WO-1998054188-A1 | FUSED DIHYDROPYRANS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1998-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090048287-A1 | Compositions useful for treating gastrointestinal motility disorders | HRH2, MLNR, HTR3A | RET 2400/4885KDR 4782/4885ATP4A 1096/4885 |
| US-20050059704-A1 | Compositions useful for treating gastrointestinal motility disorders | HRH2, MLNR, HTR3A | RET 2400/4885KDR 4782/4885ATP4A 1096/4885 |
| US-20060189648-A1 | Compositions useful for increasing lower esophageal sphincter pressure | HTR3A, HTR3D, HTR3B | RET 2977/4885KDR 4838/4885ATP4A 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.